Biodesix Stockholders Approve All Proposals at 2026 Annual Meeting

Biodesix, Inc. held its 2026 annual meeting of stockholders on May 19, 2026, where all four proposals submitted to a vote were approved. Stockholders elected two Class III directors, Jean Franchi and Hany Massarany, to serve until the 2029 annual meeting. Additionally, the compensation of named executive officers and the frequency of advisory votes on executive compensation (favoring one year) were approved on a non-binding advisory basis. The appointment of KPMG LLP as the independent registered public accounting firm for the year ending December 31, 2026, was also ratified.